| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/08/2004 | US20040005661 Comprises mitogenic factor for propagation neuronal cells and treating nervous system disorders |
| 01/08/2004 | US20040005660 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | US20040005658 Embryonic protein for diagnosis, prevention and treatment of tumors, blood, viral and immunological disorders |
| 01/08/2004 | US20040005657 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005656 Novel GPCR-like proteins and nucleic acids encoding same |
| 01/08/2004 | US20040005654 Method of producing polyvalent antigens |
| 01/08/2004 | US20040005647 Comprises monocolnal antibody for diagnosis and treatment of cancer; antitumor agents; tumor imaging |
| 01/08/2004 | US20040005642 Comprises expression vectors coding antiproliferative agents; antisense agents; tumor diagnosis and treatment |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005615 Amplification and overexpression of oncogenes |
| 01/08/2004 | US20040005611 PNA probes, probe sets, methods and kits pertaining to the determination of Listeria |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005603 Gene shinc-3 and diagnostic and therapeutic uses thereof |
| 01/08/2004 | US20040005602 DNA encoding the vertebrate homolog of hedgehog, Vhh-1, expressed by the notocord, and uses thereof |
| 01/08/2004 | US20040005600 Designing expression vector for improved accumulation of plasmodium protein in transformed cells |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005597 Comprises nucleotide sequences coding chaperone protein which protects enzymes and cellular systems in extreme heat; polymerase chain reaction; preventing enzymatic aggregation and intracellular precipitation during heat stress |
| 01/08/2004 | US20040005592 Materials and methods relating to therapy and diagnosis using targeting of cells that express DCAL-Hy polypeptides |
| 01/08/2004 | US20040005590 Isolated human RAS-like proteins, nucleic acid molecules encoding these human RAS-like proteins, and uses thereof |
| 01/08/2004 | US20040005588 Using DNA vaccines to treat and prevent insulin depentent diabetes mellitus |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005578 Myocardial cell proliferation-associated genes |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005571 Axs gene and protein and methods related thereto |
| 01/08/2004 | US20040005563 Detecting transcription products associated urogenital cancers drug screening; drug screening; antiproliferative agents |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005560 Comprise polynucleotide for treating cancer and inflammatory disorders; antisense therapy; gene therapy |
| 01/08/2004 | US20040005558 Proteins, polynucleotides ecoding them and methods of using the same |
| 01/08/2004 | US20040005557 Comprises polypeptide for diagnosing and treating inflammatory, nervous system, autoimmune and infectious disorders |
| 01/08/2004 | US20040005554 Novel glycoproteins and methods of use thereof |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005550 Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3 |
| 01/08/2004 | US20040005549 Comprises expression vector capable of efficient replication for use as diagnostic tool in viral gene transfer, propagation, drug screening and vaccine development |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005544 Comprise RNA viruses for diagnosis, prevention and treatment of repiratory system disorders; vaccine development; viricides; antisense therapy |
| 01/08/2004 | US20040005542 Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
| 01/08/2004 | US20040005541 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
| 01/08/2004 | US20040005539 Comprises expression vector coding antibody domains and heterologous proteins for use as model in design of improved binding domains; enzyme inhibitors |
| 01/08/2004 | US20040005538 Crystalline human CR2 protein in complex with C3d, and the three dimensional structure of the crystalline complex. Also disclosed are methods of use of the structure, particularly for structure-based identification of compounds that bind to |
| 01/08/2004 | US20040005537 Method of identifying toxic agents using differential gene expression |
| 01/08/2004 | US20040005338 Virus like particles (VLPs) can be loaded and packaged, respectively, with DNA oligonucleotides rich in non-methylated C and G (CpGs). If such CpG-VLPs are mixed with antigens, the immunogenicity of these antigens are |
| 01/08/2004 | US20040005334 Redirection of cellular immunity by receptor chimeras |
| 01/08/2004 | US20040005332 Application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native |
| 01/08/2004 | US20040005331 Polypeptides and fragments of polypeptides containing histidine triad residues or coiled-coil regions, some of which polypeptides or fragments lie between 80 and 680 residues in length. Also disclosed are processes for |
| 01/08/2004 | US20040005330 Mutated HIV Tat |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005326 Leishmania vaccine |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005320 Treating IL-20 induced inflammation. An antagonist to IL-20 is administered to treat inflammation and associated diseases. The antagonist can be an antibody that binds to IL-20 or its receptor or a soluble receptor that binds to IL-20. Adult |
| 01/08/2004 | US20040005319 Connective tissue growth factor |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005317 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040005309 Targeted therapeutic proteins |
| 01/08/2004 | US20040005307 Modulators of amyloid aggregation |
| 01/08/2004 | US20040005296 Gene therapy targeted to ischemic tissues. |
| 01/08/2004 | US20040005276 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 01/08/2004 | DE10226674A1 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/08/2004 | DE10163755A1 Tumor-Peptidantigene aus humanem CD19-Protein Tumor peptide antigens from human CD19 protein |
| 01/08/2004 | CA2542171A1 Modulators and modulation of the interaction between rgm and neogenin |
| 01/08/2004 | CA2492131A1 Live replicating spumavirus vector |
| 01/08/2004 | CA2492053A1 Peptides with antimicrobial properties and compounds containing same, particularly for preserving food |
| 01/08/2004 | CA2491567A1 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | CA2491344A1 Marked peptides having affinity for a phospholipid and uses |
| 01/08/2004 | CA2491343A1 Peptides having affinity for a phospholipid and uses |
| 01/08/2004 | CA2491212A1 Protein production methods and modified cells for use therein |
| 01/08/2004 | CA2491083A1 Novel polynucleotide and polypeptide sequences and uses thereof |
| 01/08/2004 | CA2491001A1 Novel use of lipopeptide preparations |
| 01/08/2004 | CA2490918A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 01/08/2004 | CA2490885A1 Avian cytokines, such as il-12, comprising a p40 and/or p35 subunit(s) |
| 01/08/2004 | CA2490866A1 Viruses and virus-like particles for multiple antigen and target display |
| 01/08/2004 | CA2490781A1 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 01/08/2004 | CA2490713A1 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 01/08/2004 | CA2490621A1 Cngh0005 polypeptides, antibodies, compositions, methods and uses |
| 01/08/2004 | CA2490548A1 Genes encoding proteins with pesticidal activity |
| 01/08/2004 | CA2490533A1 Cngh0004 polypeptides, antibodies, compositions, methods and uses |
| 01/08/2004 | CA2490348A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490256A1 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | CA2489515A1 Methods and compositions for modulating and detecting wisp activity |
| 01/08/2004 | CA2487712A1 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | CA2486538A1 Pain signaling molecules |
| 01/08/2004 | CA2473733A1 Cytokine receptor zcytor17 multimers |
| 01/07/2004 | EP1378810A2 System and methods to regulate use of consumer devices and services |
| 01/07/2004 | EP1378749A1 Screening method |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378519A1 Scianna antigens |
| 01/07/2004 | EP1378518A1 RGS2 as a biomarker for macrophage activation and for activated-macrophage-related disorder |